Business Summary
Pervasis Therapeutics, Inc. is a United States-based biotechnology Company that develops biological active therapies. The Company devices used to regulate vascular repair and restore blood flow to organs and vasculature. Its Vascugel is a cell-based therapeutic matrix, which is designed to treat vascular injury in various clinical settings, such as vascular access, coronary bypass graft, limb salvage, and peripheral bypass failure. The Companys clinical program improves vascular access procedures for hemodialysis patients, and reducing complications following angioplasty or stent implants for peripheral arterial disease. The Company was formerly known as ELV, Inc.
Country of Incorporation
United States of America
Incorporation Date
2003-09-22
Business Sector
Pharmaceuticals & Medical Research
Company Address
1000 Winter Street Suite 3350